The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspectiveJan Zeidler, Wolfgang Greiner, Lara Slawik et al.|Health Economics Review|2012Cited by 42
Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in GermanyJan Zeidler, Stephan Heres, Jörg Mahlich et al.|Applied Health Economics and Health Policy|2013Cited by 31
Treatment costs of attention deficit hyperactivity disorder in GermanySebastian Braun, Wolfgang Greiner, Jan Zeidler et al.|The European Journal of Health Economics|2012Cited by 29
Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in GermanyJan Zeidler, Stephan Heres, Jörg Mahlich et al.|Value in Health|2013Cited by 9